Smartlab Europe

News

5 Tech Companies Shaping The Future Of Healthcare

The healthcare industry is undergoing a massive transformation. According to Statista, it's an industry that grew at a rate of 15.9% within five years from 2016, projected to reach USD$59.70 billion in 2022. Sure, the influence of technology is...

Biopharma Mergers and Acquisitions on a Rise

Deals can be just as significant in the drug development industry as scientific advancements. Without mergers and acquisitions, many of today's most significant pharmaceuticals—from the anti-inflammatory Humira to the life-saving cancer medication Keytruda—might not have come to be. Pharmaceutical M&A...

Ancient Viral DNA In Human Genome Shields From Getting Sick

According to new research, ancient infections that left viral DNA in human genomes act as antivirals to shield human cells from some modern viruses. A Science article titled Evolution and Antiviral Activity of a Human Protein of Retroviral Origin offers...

EMA Follows FDA In Restricting Immune-Regulating Medicines

On October 28th, an advisory board to the European Medicines Agency advised restricting the use of a class of medications for inflammatory diseases due to a known association with side effects like cancer and heart attacks. The group recommended limiting...

Liquid relief for dental care

Huons Global expands anesthetics production with reliable cartridge filling technology from Syntegon. Nobody really likes to feel numb until they go see a dentist. Tooth extraction or drilling becomes a little less scary when topical anesthetics are used. One of...

China Releases The First COVID Vaccination That Is Inhaled

A new type of COVID-19 vaccination that is provided via inhalation rather than injection was this week introduced in Shanghai, the commercial city of China, in what is thought to be a first for the world. In September, Chinese authorities...

Omicron Subvariants Are Immune To Major Antibody Therapies

The White House issued a warning this week that HIV patients, kidney transplant recipients, and other immunocompromised people are particularly susceptible to COVID this winter because emerging omicron subvariants are impervious to important antibody therapy. Some of the key methods...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »